Skip to main content
OpenTrials
Completed

NCT Number: NCT06108440

Comparative Effects of Action Observation and Motor Imagery on Upper Limb in Chronic Stroke Patients

To Compare effects of action observation and motor imagery training on upper limb function in chronic stroke patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Riphah International University

Lahore, Fedral, 44000, Pakistan

About this study

The study is Randomized controlled trial. The study will be conducted on 44 stroke patients. The study will be conducted in Civil Hospital Shujaabad and Riphah rehabilitation centre Lahore. Patients will be divided into Group A (n = 20) and Group B (n = 20) using a randomization through computer generated numbers program. Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks. Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks. For the pre- and post-evaluation of all participants, Fugl-Meyer Assessment Upper Extremity (FMA UE) and Wolf Motor Function Test (WMFT) will be used. Data will be analyzed by using SPSS (Statistical package for Social Sciences) 25 version.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with chronic stroke by a neurologist
  • 03 months post stroke
  • Score 1+ on modified ashworth scale
  • Having a score of 24 or higher in the Mini-Mental State Examination

Exclusion criteria

  • Patient with neurological condition other than stroke e.g. Parkinson's or multiple sclerosis
  • Presence of an attached artificial pacemaker
  • Presence of a metal implant in the brain
  • Presence of visual impairment
  • Presence of unilateral neglect in Line bisection test (25)
  • Use of antipsychotic drugs

Treatment and study plan

Action Observation training

Other

Patients in Group A will receive action observation training with conventional treatment. All participants will undergo the training for 25 minutes per session, 5 days per week for 8 weeks.

Motor Imagery Training

Other

Patients in Group B will receive motor imagery with conventional treatment. All participants will receive interventions for twenty-five minutes per session, five times a week, for eight weeks.

Primary outcomes

  1. Fugl-Meyer Assessment Upper Extremity (FMA UE):

    Time frame: 6 months

    Fugl-Meyer Assessment Upper Extremity (FMA UE):

    FMA UE is a detailed evaluation tool that quantitatively measures motor function, balance, sensation, joint range of motion, and pain in stroke hemiplegic patients

  2. Wolf Motor Function Test (WMFT):

    Time frame: 6 months

    Wolf Motor Function Test (WMFT):

    The Wolf motor function test is a tool to evaluate upper extremity motor function in hemiplegic patients. It has 17 tasks with a score range from 0-5. The inter-rater reliability of the function score is 0.88 and the inter-rated reliability of performance time is 0.97

Sponsors and collaborators

Lead sponsor

Riphah International University

Other

Registry information

Official study title

Comparative Effects of Action Observation and Motor Imagery Training on Upper Limb Function in Chronic Stroke Patients

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 31, 2023
Registry last updated
Mar 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.